Merck, known as MSD outside of the United States and Canada, announced on July 13, 2020 that it has signed a collaboration agreement with Dewpoint Therapeutics, a biomolecular condensates company located in Boston, MA, for approximately $305 million to use Dewpoint s proprietary platform for con